IMAdult ≥20 yr 20 mcg/mL. Neonate, infant & childn up to & including 19 yr 10 mcg/0.5 mL. All doses to be given at 0, 1, 6 mth; or 0, 1, 2 + booster at 12 mth; or 0, 7, 21 days + booster at 12 mth (for subjects ≥20 yr only).
Do not administer in the buttock, intradermally or intravascularly. Postpone administration in acute febrile illness. Renal insufficiency, haemodialysis, HIV-infected or impaired immunity. Risk of apnoea & resp monitoring for 48-72 hr in very premature infants (≤28 wk of gestation) & those w/ history of resp immaturity. Consider additional doses in adult >40 yr. Pregnancy.
Loss of appetite, irritability, headache, drowsiness, GI symptoms, inj site reactions, fatigue, malaise, fever (≥37.5°C).